Gonococcal antimicrobial susceptibility surveillance in Europe, 2017

surveillance report
Publication series: Gonococcal antimicrobial susceptibility surveillance in Europe

The overall aim of Euro-GASP is to strengthen the surveillance of gonococcal antimicrobial susceptibility in EU/EEA Member States in order to provide quality-assured data to inform gonorrhoea treatment guidelines. This report presents the results from the 2016 gonococcal antimicrobial susceptibility sentinel surveillance.

Related updates on Neisseria gonorrhoeae

News

Gonorrhoea cases on the rise across Europe

news story -

Publication

Gonorrhoea - Annual Epidemiological Report for 2017

surveillance report -

News

Extensively drug-resistant gonorrhoea: risk of further dissemination within and across Europe

ECDC comment -

News

Gonorrhoea: drug resistance compromises recommended treatment in Europe

news story -

Publication

Communicable disease threats report, 17-23 February 2019, week 8

publication -